Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - Total assets
Total assets on the balance sheet as of December 2023 : $0.17 B
According to Marinus Pharmaceuticals's latest financial reports the company's total assets are $0.17 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Marinus Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -34.14% |
| 2022-12-31 | $0.25 B | 89.65% |
| 2021-12-31 | $0.13 B | -9.05% |
| 2020-12-31 | $0.15 B | 52.22% |
| 2019-12-31 | $98.84 M | 31.38% |
| 2018-12-31 | $75.23 M | 24% |
| 2017-12-31 | $60.67 M | 92.93% |
| 2016-12-31 | $31.44 M | -47.28% |
| 2015-12-31 | $59.64 M | 18.79% |
| 2014-12-31 | $50.21 M | 324.67% |
| 2013-12-31 | $11.82 M | 36.19% |
| 2012-12-31 | $8.68 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $1.27 B | 647.58% | 🇺🇸 USA |
 Endo International
ENDPQ | $5.13 B | 2,905.88% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | $20.39 M | -88.07% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.40 B | 136.87% | 🇺🇸 USA |